Effects of Regular Exercise and Psychoeducation on Quality of Life and Depression in the Treatment of Sarcopenia
2 other identifiers
interventional
40
1 country
1
Brief Summary
In this study, it was aimed to observe the effect of psychoeducation, which has not yet been included among the treatment methods of sarcopenia, which affects elderly individuals both physically and psychologically and has been proven to negatively affect their quality of life, on Quality of Life, Depression and Physical Function when applied with exercise therapy. It is known that exercise programs applied in the treatment of sarcopenia, which has become a common problem in elderly individuals and is known as the trigger of most symptomatic diseases, have positive effects. However, no psychoeducation program has been applied to date in the treatment of sarcopenia, which is thought to trigger psychological factors as well as physical factors. In this direction, it is aimed to contribute to sarcopenia treatment and indirectly to geriatric rehabilitation programs according to the results we will obtain in sarcopenic individuals with the psychoeducation program, which we think is lacking. In addition to all these, sarcopenia, which is a treatable diagnosis and one of the biggest obstacles to the independent life of elderly individuals, is thought to be a preventable condition with preventive rehabilitation programs. Researchers believe that preventive rehabilitation programs will positively affect the amount spent on elderly care services, which constitute a large portion of our country's health expenses, and Researchers aim to support these issues with the results they will obtain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2024
CompletedFirst Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedMarch 11, 2025
March 1, 2025
14 days
February 25, 2025
March 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
TUG test
A chair and a stopwatch are required for the test, which evaluates the risk of falls and mobility in the elderly. The test is performed with the shoes the individual always uses. A 3-meter area is determined in front of the chair. The individual is asked to get up from the chair, walk this distance, and sit down again.
Before treatment
SF-12 Test
It is an abbreviated form for assessing quality of life. This form, developed by Ware et al. (1995), is not specific to any age or type of disease, but is a scale that assesses the person's quality of life over the last four weeks. SF-12; It includes the sub-elements of physical functioning, physical role, pain, general health, emotional role, mental health, social functioning and vitality and consists of 12 questions.
Before treatment
GDS
This scale was developed by Yesavage et al. (1983). The Turkish adaptation of the scale was made by Ertan et al. The scale is self-reporting, aimed at the elderly, easy to answer and consists of 30 questions. A higher score indicates a higher level of depression.
Before treatment
Bioelectrical impedance analysis (BIA)
Bioelectrical impedance analysis (BIA) measurement; It is a non-invasive measurement. It takes advantage of the different resistance of different tissues in the body to currents. A weak electric current is directed to the body and the impedance is measured. It is used to estimate body composition parameters such as total body water and fat-free mass.
Before treatment
SARC-F
SARC-F; It allows health professionals to quickly and easily assess the risk of sarcopenia in primary health care. It asks 5 questions about "strength, assistance while walking, getting up from a chair, climbing stairs and falling". The SARC-F score range is from 0 to 10, with a score range of 0-3 representing a healthy condition and a score range of 4 and above representing a symptomatic condition.
Before treatment
Standardized Mini Mental Test (SMMT)
Mini Mental Test developed by Folstein et al. (1975) allows for cognitive assessment in a short time. In this respect, SMMT is a short, easy-to-apply and standardized test used to determine the cognitive level globally.
Before treatment , pre test only
Handgrip strength assessment
During the assessment, the individual is seated upright on a chair without surface support for the arm being assessed. The arm to be measured is positioned in a free position, with the knee angle and elbow angle at 90 degrees. The subject is asked to squeeze the dynamometer with their fingers as hard and tight as possible. The measurements are repeated 3 times, with 10 seconds between them and each measurement being no less than 5 seconds, and any interventions that may affect the measurements during the assessment are avoided.
Before treatment
Secondary Outcomes (5)
TUG test
Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)
SF-12 Test
Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)
GDS
Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)
Bioelectrical impedance analysis (BIA)
Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)
Handgrip strength assessment
Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)
Study Arms (3)
control
NO INTERVENTIONThis group will be informed about exercise and psychoeducation only once after the sessions are completed.
exercise
ACTIVE COMPARATORPhysical exercise will be performed for 45 minutes twice a week for eight weeks.
exercise and psychoeducation
ACTIVE COMPARATORA 45-minute exercise program twice a week and a 45-minute psychoeducation program once a week will be implemented for 8 weeks.
Interventions
Although the literature investigating the effectiveness of exercise programs on quality of life, physical function and depression in sarcopenic individuals is extensive, no studies have been found in which psychoeducation programs are applied to sarcopenic individuals and their effectiveness is investigated. In this planned study,Researchers aim to observe what kind of results will emerge and in what direction the psychoeducation program will shape the treatment by applying both exercise and psychoeducation programs to sarcopenic individuals.
Although the literature investigating the effectiveness of exercise programs on quality of life, physical function and depression in sarcopenic individuals is extensive, no studies have been found in which psychoeducation programs are applied to sarcopenic individuals and their effectiveness is investigated. In this planned study, Researchers aim to observe what kind of results will emerge and in what direction the psychoeducation program will shape the treatment by applying both exercise and psychoeducation programs to sarcopenic individuals.
Eligibility Criteria
You may qualify if:
- Individuals aged 60 and over who have signed a consent form and agreed to volunteer for the study.
- Individuals classified as sarcopenic according to the criteria of the European Working Group on Sarcopenia (EWGSOP2).
- Individuals who scored 24 points or higher on the Standardized Mini Mental Test.
You may not qualify if:
- Individuals with neurological disease,
- Individuals with advanced kidney disease,
- Individuals with pacemakers,
- Individuals with advanced vision and hearing problems,
- Individuals with advanced dementia,
- Individuals with orthopedic disabilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ondokuz Mayıs University
Samsun, 55400, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Esra Erdoğan
Ondokuz Mayıs University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical physiotherapist
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 11, 2025
Study Start
June 1, 2024
Primary Completion
June 15, 2024
Study Completion
September 28, 2024
Last Updated
March 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
All IPD collected